Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively
Status:
Terminated
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
DAWA is a phase 2, prospective, open-label, randomized, pilot study. The main variable to be
observed in this study is intracardiac thrombus. There are no formal primary or secondary
clinical efficacy or safety outcomes because it is a pilot study.